Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2024-12-11 00:00:00 ET · period of report 2024-12-09 · accession 0001437749-24-037274 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-11 | 2024-12-09 | LMAT | Ross Bridget A | Dir | M - OptEx | $0.00 | +1 | 2,699 | +0.0% | $0 |
| D | 2024-12-11 | 2024-12-09 | LMAT | Ross Bridget A | Dir | M - OptEx | $0.00 | -1 | 3.01 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-09 | M | A | 1 | $0.00 | 2,699 | D | — | — | (F1) Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. |
| 2 | Derivative | Dividend Equivalent Rights | 2024-12-09 | M | D | 1 | $0.00 | 3.01 | D | — · — to — | 1 Common Stock | (F2) These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |